RetinAI Discovery favicon

RetinAI Discovery
Transformative AI & data management platform for healthcare decision-making

What is RetinAI Discovery?

RetinAI Discovery stands at the forefront of healthcare innovation, offering a comprehensive data management and analysis platform specifically designed for ophthalmology. The platform seamlessly integrates multiple data formats, from DICOM-compliant imaging to proprietary formats, while providing advanced AI-powered analysis capabilities for disease progression and treatment outcomes.

The platform features CE-marked AI models for OCT analysis, layer and fluid segmentation, and supports various ophthalmological conditions including AMD, DR, DME, CME, and GA. With its cloud-based infrastructure, the system enables secure global collaboration, real-time data monitoring, and automated biomarker analysis, serving both clinical practice and research environments.

Features

  • AI Analysis: CE-marked biomarkers and automatic layer and fluid segmentation
  • Data Integration: Support for multiple imaging formats and data types
  • Secure Collaboration: GDPR, HIPAA & PIPEDA compliant platform
  • Real-time Monitoring: Instant access to study progress and patient data
  • Automated Biomarker Analysis: 30+ CE marked and Research Use Only biomarkers
  • Natural Language Search: Advanced patient cohort identification
  • Multi-center Management: Centralized data collection and analysis
  • Disease-Specific Focus: Specialized tools for AMD, DR, DME, CME and GA

Use Cases

  • Clinical trial data management
  • Patient monitoring and disease progression tracking
  • Multi-center research collaboration
  • Real-world evidence generation
  • Ophthalmology imaging analysis
  • Tele-ophthalmology services
  • Drug development research
  • Clinical decision support

FAQs

  • What types of medical imaging formats does RetinAI Discovery support?
    RetinAI Discovery supports DICOM-compliant formats, OCTs, Fundus images, PDFs, JPEG, PNG & TIFF files.
  • What security compliance standards does the platform meet?
    The platform is compliant with EU GDPR, HIPAA & Canadian PIPEDA rules for data privacy and security.
  • What eye conditions can the AI models analyze?
    The platform supports assessment of AMD, DR, DME, CME and GA (Geographic Atrophy) conditions.

Related Queries

Helpful for people in the following professions

RetinAI Discovery Uptime Monitor

Average Uptime

100%

Average Response Time

367.27 ms

Last 30 Days

Related Tools:

Blogs:

Comparisons:

Didn't find tool you were looking for?

Be as detailed as possible for better results